Welcome to Leadenhall Capital Partners LLP,
a London based investment manager wholly focused on investing in insurance linked investments portfolios for institutional investors.
Leadenhall Capital Partners offers dedicated funds and managed accounts which give institutional investors access to both life and non-life insurance linked investments. Investors benefit from the attractive returns of the sector, whilst diversifying their risks from the traditional capital markets.
Many instruments, such as cat bonds and private placements of collateralised reinsurance, are used to transfer insurance linked risk to the capital markets. Leadenhall uses all of them to ensure liquidity, profitability, diversification and growth.
16 June 2016
Leadenhall was awarded the 2016 Trading Risk Investor of the Year Award for the second time in four years, a unique achievement as no other ILS manager has won more than once. Below the official release made by Trading risk: “In its first full year after Amlin increased its shareholding in Leadenhall Capital Partners, the London-based ILS fund continued to expand its capital base. Leadenhall invests across a wide range of products, both life and non-life as well as catastrophe bonds and private placements – giving investors and protection buyers a full suite of options. Partnering with Amlin has enabled Leadenhall to achieve its target signings on private reinsurance deals. Judges described Leadenhall’s approach as delivering a “joined-up” service with the rated reinsurer, without being beholden to the carrier. The manager’s funds delivered on their return targets in 2015.”
The promotion of hedge funds is restricted in some jurisdictions. In the UK, this is dependant on net worth and level of investment experience. US investors must meet the criteria to be accredited and qualified investors. Other jurisdictions have different requirements and you should check whether you are eligible to access promotional material.
If you are a qualified institutional investor interested in receiving information about our company and funds offering please contact:
Office: +44 (0)20 7746 1690
Mobile: +44 (0)77 2592 4836